SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000885590-18-000027
Filing Date
2018-05-08
Accepted
2018-05-08 07:06:34
Documents
5
Period of Report
2018-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k-q1x2018pressrelease.htm 8-K 29229
2 EXHIBIT 99.1 ex991-q1x2018.htm EX-99.1 588128
3 EXHIBIT 99.2 ex992-q1x2018.htm EX-99.2 13690
4 g274847img1a03.jpg GRAPHIC 17603
5 valeantlogofooter2.gif GRAPHIC 8312
  Complete submission text file 0000885590-18-000027.txt   668338
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 18812923
SIC: 2834 Pharmaceutical Preparations